Tudor Investment Corp’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-52,980
| Closed | -$1.16M | – | 1542 |
|
|
2025
Q1 | $1.16M | Buy |
+52,980
| New | +$1.16M | ﹤0.01% | 979 |
|
|
2024
Q4 | – | Sell |
-73,002
| Closed | -$2.11M | – | 1523 |
|
|
2024
Q3 | $2.11M | Buy |
+73,002
| New | +$2.11M | 0.01% | 738 |
|
|
2024
Q1 | – | Sell |
-9,962
| Closed | -$596K | – | 1441 |
|
|
2023
Q4 | $596K | Sell |
9,962
-40,150
| -80% | -$2.4M | ﹤0.01% | 1085 |
|
|
2023
Q3 | $1.91M | Buy |
50,112
+42,714
| +577% | +$1.62M | 0.02% | 664 |
|
|
2023
Q2 | $674K | Buy |
+7,398
| New | +$674K | 0.01% | 1036 |
|
|
2022
Q3 | – | Sell |
-34,707
| Closed | -$1.57M | – | 1566 |
|
|
2022
Q2 | $1.57M | Sell |
34,707
-14,133
| -29% | -$639K | 0.04% | 590 |
|
|
2022
Q1 | $2.48M | Buy |
+48,840
| New | +$2.48M | 0.06% | 431 |
|
|
2021
Q4 | – | Sell |
-150,703
| Closed | -$4.97M | – | 1593 |
|
|
2021
Q3 | $4.97M | Buy |
150,703
+128,065
| +566% | +$4.22M | 0.08% | 232 |
|
|
2021
Q2 | $1.43M | Buy |
+22,638
| New | +$1.43M | 0.03% | 668 |
|
|
2021
Q1 | – | Sell |
-29,448
| Closed | -$1.68M | – | 1504 |
|
|
2020
Q4 | $1.68M | Buy |
29,448
+9,507
| +48% | +$544K | 0.05% | 476 |
|
|
2020
Q3 | $602K | Buy |
+19,941
| New | +$602K | 0.03% | 739 |
|